PSMA6 and renal cell carcinoma: When further stratified by sex (Table 4), a strong association between alpha-1 blocker use and RCC was found in men (HR, 1.89; 95% CI, 1.49−2.39) but not in women (HR, 1.44; 95% CI, 0.99−2.11).